Rous-Whipple Award Lecture. The Alzheimer's brain: finding out what's broken tells us how to fix it
- PMID: 16251403
- PMCID: PMC1603781
- DOI: 10.1016/s0002-9440(10)61206-0
Rous-Whipple Award Lecture. The Alzheimer's brain: finding out what's broken tells us how to fix it
Figures
Similar articles
-
The Mechanistic Link Between Tau-Driven Proteotoxic Stress and Cellular Senescence in Alzheimer's Disease.Int J Mol Sci. 2024 Nov 17;25(22):12335. doi: 10.3390/ijms252212335. Int J Mol Sci. 2024. PMID: 39596399 Free PMC article. Review.
-
Morphometry of medial temporal lobe subregions using high-resolution T2-weighted MRI in ADNI3: Why, how, and what's next?Alzheimers Dement. 2024 Nov;20(11):8113-8128. doi: 10.1002/alz.14161. Epub 2024 Sep 16. Alzheimers Dement. 2024. PMID: 39279366 Free PMC article. Review.
-
Protein tau phosphorylation in the proline rich region and its implication in the progression of Alzheimer's disease.Exp Neurol. 2025 Jan;383:115049. doi: 10.1016/j.expneurol.2024.115049. Epub 2024 Nov 8. Exp Neurol. 2025. PMID: 39522802
-
Fazekas scale magnetic resonance imaging assessment in Alzheimer's disease and primary age-related tauopathy.Neuroradiology. 2024 Dec;66(12):2185-2193. doi: 10.1007/s00234-024-03464-2. Epub 2024 Sep 26. Neuroradiology. 2024. PMID: 39325192 Free PMC article.
-
The Alzheimer's disease mitochondrial cascade hypothesis: an update.Exp Neurol. 2009 Aug;218(2):308-15. doi: 10.1016/j.expneurol.2009.01.011. Epub 2009 Jan 29. Exp Neurol. 2009. PMID: 19416677 Free PMC article. Review.
Cited by
-
The origin and development of plaques and phosphorylated tau are associated with axonopathy in Alzheimer's disease.Neurosci Bull. 2011 Oct;27(5):287-99. doi: 10.1007/s12264-011-1736-7. Neurosci Bull. 2011. PMID: 21934724 Free PMC article.
-
Exploring the Therapeutic Potential of Alkaloids in Alzheimer's Disease Management.Cent Nerv Syst Agents Med Chem. 2024;24(2):206-218. doi: 10.2174/0118715249269092231109181638. Cent Nerv Syst Agents Med Chem. 2024. PMID: 38213138
-
Nuclear and cytosolic JNK signalling in neurons.Nat Rev Neurosci. 2014 May;15(5):285-99. doi: 10.1038/nrn3729. Nat Rev Neurosci. 2014. PMID: 24739785 Review.
-
_target identification for CNS diseases by transcriptional profiling.Neuropsychopharmacology. 2009 Jan;34(1):18-54. doi: 10.1038/npp.2008.172. Epub 2008 Oct 15. Neuropsychopharmacology. 2009. PMID: 18923405 Free PMC article. Review.
-
Single cell gene expression profiling in Alzheimer's disease.NeuroRx. 2006 Jul;3(3):302-18. doi: 10.1016/j.nurx.2006.05.007. NeuroRx. 2006. PMID: 16815214 Free PMC article. Review.
References
-
- Forman MS, Trojanowski JQ, Lee VM-Y. Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs. Nat Med. 2004;10:1055–1063. - PubMed
-
- Skovronsky DM, Lee VM-Y, Trojanowski JQ: Neurodegenerative diseases: new concepts of pathogenesis and their therapeutic implications. Annu Rev Pathol (in press) - PubMed
-
- Suh Y-H, Checler F. Amyloid precursor protein, presenilins and alpha-synuclein: molecular pathogenesis and pharmacological applications in Alzheimer’s disease. Pharmacol Rev. 2002;54:469–525. - PubMed
-
- Lee VM-Y, Balin BJ, Otvos L, Trojanowski JQ. A68: a major subunit of paired helical filaments and derivatized forms of normal tau. Science. 1991;251:675–678. - PubMed
-
- Bramblett GT, Goedert M, Jakes R, Merrick SE, Trojanowski JQ, Lee VM-Y. Abnormal tau phosphorylation at Ser396 in Alzheimer’s disease recapitulates development and contributes to reduced microtubule binding. Neuron. 1993;10:1089–1099. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical